Serum Institute of India Pvt. Ltd. manufactures several vaccines, which include Polio, Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. 65% children in the world are estimated to receive at least one vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization.
Source: http://www.seruminstitute.com/
Serum Institute of India – Protection from birth onwards
| 2021 | Serum Institute Life Sciences Private Limited (SILS) and Biocon Biologics Limited (BBL) announced a strategic alliance to develop antibodies for infectious diseases such as dengue, HIV, and others. In June 2021, SII announced plans to launch Novavax's COVID-19 vaccine 'Covovax' in India by September 2021 Government of India signed a deal to procure 20 million doses of its COVID-19 vaccination. |
| 2020 | Launched India’s first fully indigenously developed pneumococcal vaccine, 'Pneumosil' |
| 2016 | Launched world’s first rabies human monoclonal antibody, recombinant |
| 2014 | Launched oral polio vaccine |
| 2012 | Acquired Bilthoven Biologicals, Netherlands Launched Trivalent seasonal influenza vaccine |
| 2011 | Launched injectable inactivated polio vaccine |
| 2010 | Launched H1N1 influenza vaccine |
| 2009 | Launched liquid pentavalent vaccine (DPT-HepB-Hib) (PENAVAC SD/PFS) |
| 2007 | Launched Hib vaccine and BCG vaccine for bladder cancer |
| 2002 | Launched BCG vaccine |
| 2001 | Launched Hepatitis B vaccine |
| 1993 | Launched MMR vaccine |
| 1989 | Launched measles vaccine |
| 1974 | Commenced production of DTP vaccine |